A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.
Akihiro YonedaHiroyuki ShichinoTomoro HishikiKimikazu MatsumotoMiki OhiraTakehiko KamijoTatsuo KurodaToshinori SoejimaAtsuko NakazawaTetsuya TakimotoIsao YokotaSatoshi TeramukaiHideto TakahashiTakashi FukushimaJunichi HaraMichio KanekoHitoshi IkedaTatsuro TajiriHideo MugishimaAkira NakagawaraPublished in: Pediatric blood & cancer (2024)
This study indicates that delayed local treatment is feasible and shows promising efficacy, suggesting that this treatment should be considered further in a comparative study of high-risk neuroblastoma.